Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Synchronous fallopian tube and breast cancers: case report and literature review
1Department of Gynecology, Sacra Cuore Hospital, Negrar (VR), Italy
2Department of Gynecology, Domodossola Hospital, Domodossola (VB), Italy
3Department of Pathology, Sacra Cuore Hospital, Negrar (VR), Italy
4Department of Medical Oncology, Sacra Cuore Hospital, Negrar (VR), Italy
5Department of Gynecology, Mirano Hospital, Mirano (VE), Italy
*Corresponding Author(s): C. Romagnolo E-mail:
A case of fallopian tube cancer was intraoperatively diagnosed in a patient submitted to laparoscopic hysterectomy and bilateral salpingo-oophorectomy because of an ultrasound diagnosis of a probable endometriotic cyst of the right ovary. Postoperatively a complete staging was performed and a synchronous carcinoma of the breast was diagnosed. Consequently the patient completed laparotomic debulking and a left mastectomy. A case of a premenopausal woman with fallopian tube cancer and synchronous breast cancer is reported together with a review of the most recent literature.
Synchronous cancers; Breast cancer; Fallopian tube cancer
C. Romagnolo,A. Gabriele,G. Zamboni,P. Cassandrini,T. Maggino. Synchronous fallopian tube and breast cancers: case report and literature review. European Journal of Gynaecological Oncology. 2003. 24(1);73-75.
[1] Case T. C.: " Cancer of the breast with metastasis to the fallopian tube". J. Am. Geriatr. Soc., 1968, 16, 832.
[2] Fishman A., SteelB . L.,G irtanner R. E.,K aplan A. L.: "Fallopian tube cancer metastatic to the breast". Eur. J. Gynaecol. Oncol., 1994, 15, 101.
[3] Bortolozzi G., Maggi R., Arnoletti E., Garsia S., Mangili G.: "Primary carcinoma of the fallopian tube: cases from 1971 to 1985 (27 patients). Current therapeutic approaches". Ann. Ostet. Gine(.of. Med. Perina/., 1989, 110, 7.
[4] Decorsiere J.B..B ouissou H.,B ecue J.: "Primary bilateral tubular adenocarcinoma with antecedents of invasivegalactophoric carcinoma of the breast. Apropos of a case; review of the literature". Ann. Pathol., 1984, 4, 383.
[5] Sonnendecker H. E., Cooper K., Kalian K. N.: "Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma". Gynecol. Oncol., 1994, 52, 402.
[6] Seound M. A., Johnson J., Weed I. C. Jr.: "Gynecologic tumors in tamoxifen-treated women with breast cancer". Obstet. Gynecol., 1993, 82, 165.
[7] Aydiner A., Karadeniz A., Uygun K., Tas F., Disci R.,T opuz E.: " Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms". Am. J. Clin. Oncol., 2000, 23, 364.
[8] Ishioka S. I., Sagae S., Kabayashi K., Sugimura M., Nishioka Y., Kudo R.: " A case of simultaneous presence of primary endometrial carcinoma and metastasis of a breast carcinoma to the ovary after 5 years of tamoxifen therapy". J. Obstet. Gynecol. Res.,1999, 25, 113.
[9] Bonifacino A., Lauro S.,F assone F.,B ernardi G., Graziano P., Frati L.: " Peritoneal carcinomatosis in ovarian cancer and synchronous breast cancer". Giorn. Ital. Ultrason., 1995, 6, 25.
[10] Voravud N., Dimopoulos M., Hortobagyi G., Ross M., Theriault R.: "Breast cancer and second primary ovarian cancer in dermatomyositis". Gynecol. Oneal., 1991, 43, 286.
[11] Bokhman J.B.,M aximov S. J.: " Relative risk of development and active detection of primary multiple endometrial breast and ovarian cancer". Eur. J. Gynecol. Oneal., 1993, 14, 114.
[12] Aziz S,,K uperstein G.,R osenB .,C ole D.,N edelcu R.,M cLaughJin J,, Narod S. A.: "A genetic epidemiological study of the carcinoma of the fallopian tube". Gyneco/, Oneal., 2001, 80, 341.
[13] Boyd J.: "BRCA: the breast, ovarian, and other cancer genes". Gynecol. Oneal., 2001, 80, 337.
[14] Schubert E, L.,L ee M, K.,M e仆ord H. C.,A rgonza R. H,,M orrow J. E, Hull J. et al.: “BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCAI or BRCA2". Am. J. Hum. Genet., 1997, 60, 1031.
[15] Tong D., Stimpfl M., Reinthaller A., Vavra N., Mullauer-Ertl S., Leodolter S., Zeillinger R.: "BRCAI gene mutation in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization". Clin. Chem., 1999, 45, 976.
[16] Zweemer R. P., van Diest P. J., Verheijen R. H., Ryan A., Gille J J., Sijmons R. H. et al.: "Molecular evidence linking primary cancer of the fallopian tube to BRCAI germline mutations" Gynecol. Oneal., 2000, 76, 45.
[17] Rose P. G., Shrigley R., Wiesner G. L.: "Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report" Gynecol. Oneal., 2000, 77, 319.
[18] Paley P. J.,S wisher E. M.,G arcia R. L.,A goff S. N.,G reer B. E., Peters K. L., Goff B. A.: "Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophyl axis". Gynecol. Oneal., 2001, 80, 176.
[19] Ferrazzi E., Zanella G., Dordoni D.,B erlanda N、Mezzopane R., Lissoni G.: "Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study". Ultrasound Obstet. Gynecol., 1996, 61, 68.
Top